Trial Profile
A Study to Evaluate the Efficacy and Safety of Maraviroc in Pretreated Patients With HIV-1 Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 01 Mar 2016 New trial record